Pulmonary Arterial Hypertension Clinical Trial

Worldwide's PAH clinical trial experience

October 12, 2020 | Karen Hill

Worldwide Clinical Trials has extensive experience in rare disease and pulmonary arterial hypertension (PAH) trials, which is derived from our global PAH trial experience and enhanced by our medical and scientific understanding of unique PAH trial requirements.

Your form has been successfully submitted! Click the button below to access.
VIEW PDF
Karen Hill
MEET THE AUTHOR

Karen Hill

Senior Vice President, Project Management, Cardiovascular, Endocrine & Metabolic and Real-World Evidence
LEARN MORE